Community-reported Pharmorubicin side effects:
Add Your Side Effect to the Community Database
Help Community - Describe Your Pharmorubicin Side Effect
Have You dealt with a Pharmorubicin side effect? Share your experience
Review Pharmorubicin Safety Reports submitted to FDA
Total Pharmorubicin reports: 2.Pharmorubicin FDA safety alerts: No.
Reported hospitalizations: 2.
Take Pharmorubicin Side Effects Survey, Discuss Pharmorubicin with others
FDA Reported Pharmorubicin Side Effects: malaise, interstitial lung disease, vision blurred, hyperhidrosis, dyspnoea, chills, chest pain, anaphylactic reaction, abdominal pain, vasculitis, foetal distress syndrome.
More About Pharmorubicin.
If you have questions about Pharmorubicin, you can ask a Health Expert or Ask Patient Community about Pharmorubicin.
Featured polls
- What did you do to overcome side effect?
- Did you and your doctor discuss the risks and side effects of the drug, or not?
- When you are buying over the counter medication for the first time how often, if ever, do you look for warnings about possible side effects?
- When you have a prescription filled, how often does the pharmacist tell you about side effects you may experience?
- Have you, personally, ever attempted to lose weight in your lifetime, or not?
- How easy or hard do you think it is for most people who are very overweight to lose weight?
Pharmorubicin Side Effects Report #5406574-6
Pharmacist from AUSTRALIA reported PHARMORUBICIN problem on July 25, 2007. Female patient, weighting 138.9 lb, was diagnosed with breast cancer and was treated with PHARMORUBICIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, anaphylactic reaction, chest pain, chills, dyspnoea, hyperhidrosis, malaise, vision blurred. PHARMORUBICIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.
Pharmorubicin Side Effects Report #5310757-3
PHARMORUBICIN problem was reported by a Physician from JAPAN on Apr 18, 2007. Female patient, weighting 105.6 lb, was diagnosed with breast cancer and was treated with PHARMORUBICIN. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. PHARMORUBICIN dosage: unknown. During the same period patient was treated with ENDOXAN, NASEA, DECADRON, RINDERON. Patient was hospitalized. Patient recovered.